On June 9, AVAC Vietnam Joint Stock Company - one of the country's leading vaccine manufacturers - exported its first batch of AVAC ASF LIVE vaccine, consisting of 120,000 doses, to Indonesia. This marks a significant milestone in Vietnam's journey to bring its veterinary vaccines to the global market.
Mr. Nguyen Van Diep, CEO of AVAC Vietnam, said the successful export of AVAC ASF LIVE to Indonesia demonstrates the outstanding quality of the product, which passed the rigorous technical assessments of the Indonesian Ministry of Agriculture. He emphasized that this is not only an achievement for AVAC but also a significant step forward for Vietnam's veterinary vaccine industry.
AVAC ASF LIVE is the world's first successfully developed and commercialized live attenuated vaccine against African Swine Fever (ASF). It was researched, developed, and produced entirely by AVAC Vietnam. This breakthrough reflects Vietnam's advanced scientific and technological capabilities and affirms the country's growing position in the global veterinary vaccine landscape.
Currently, the AVAC ASF LIVE vaccine is undergoing registration in several other countries, including India, Malaysia, Nepal, and Myanmar.To date, AVAC has supplied over 3.5 million doses of AVAC ASF LIVE to the market. Of these, approximately 3 million doses have been used domestically in Vietnam, which is crucial in effectively controlling ASF outbreaks. An additional 500,000 doses have been exported to the Philippines and Nigeria, where they have received positive feedback from local authorities and users.
The AVAC ASF LIVE vaccine is undergoing registration procedures in several countries, including India, Malaysia, Nepal, and Myanmar. AVAC maintains a reserve of approximately 1.5 million doses to meet domestic and international demand, ready for emergency deployment. The vaccine is also under further evaluation for use in breeding pigs (sows and boars), potentially offering broader protection for Vietnam's entire pig farming sector.
A representative of the Department of Animal Health noted that the successful export of the first batch to Indonesia demonstrates the vaccine's quality and effectiveness in preventing African Swine Fever. Vietnam's success in controlling the disease is a testament to the reliability of its ASF vaccines and strengthens prospects for further exports.
All vaccine exports must undergo independent evaluation, testing, and field trials in the importing countries. According to the Department of Animal Health, Vietnam's veterinary sector is working with specialized agencies to expand the vaccine's clinical trials, registration, and efficacy assessments in other animal groups, particularly sows. Initial results indicate strong safety and effectiveness, though full conclusions await further expert evaluation.